December 4, 2024
TOPLINE: Among patients with cancer, Medicare Advantage and Medicare Part D prescription drug plans frequently used prior authorization for ondansetron and often imposed quantity limits on […]
December 2, 2024
(Reuters) – Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving […]
December 2, 2024
US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the […]
December 2, 2024
TOPLINE: At 1 year, 82% of patients with breast cancer who received a 1-week ultrahypofractionated breast radiotherapy regimen reported no or mild toxicities. Most patients also […]
December 2, 2024
SAN DIEGO — Groundbreaking studies into leukemia treatments and the effects of glucagon-like peptide 1 (GLP-1) inhibitors on venous thromboembolism (VTE) risk will be presented on […]
December 2, 2024
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. […]
November 28, 2024
TOPLINE: A group structured mindfulness intervention improves existential well-being and advance care planning self-efficacy in patients with advanced cancer. Patients also may show moderate improvements in […]
November 27, 2024
Diet is increasingly seen as a modifiable risk factor in prostate cancer. Recent studies have shown that ultralow-carbohydrate diets, weight loss diets, supplementation with omega-3 fatty […]
November 27, 2024
As a doctor with a keen interest in myeloma who is looking ahead to the 2024 American Society of Hematology (ASH) annual meeting December 7-10 in […]